This inventor holds 5 USPTO granted patents and 11 published patent applications. Top assignee: Shilpa Medicare Limited. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Karnataka, IN (2016)
- Raichur, IN (2015 - 2017)
Company Filing History:
Years Active: 2015-2017
Title: Vinod Kumar Singh: Innovator in Pharmaceutical Chemistry
Introduction
Vinod Kumar Singh is a prominent inventor based in Raichur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug formulation. With a total of 5 patents to his name, Singh's work is instrumental in advancing cancer treatment options.
Latest Patents
Singh's latest patents include a process for the preparation of Crystalline Erlotinib Hydrochloride. This invention is characterized by a specific X-ray powder diffraction pattern and is useful as an active pharmaceutical ingredient for cancer treatment. Another notable patent is the process for preparing an amorphous form of Cabazitaxel, which also demonstrates anti-cancer activity. These inventions highlight Singh's commitment to improving therapeutic options for patients.
Career Highlights
Vinod Kumar Singh is associated with Shilpa Medicare Limited, a company known for its focus on pharmaceutical innovations. His work at the company has allowed him to contribute to the development of critical medications that address serious health issues.
Collaborations
Singh has collaborated with notable colleagues such as Vimal Kumar Shrawat and Rafiuddin Dr. These partnerships have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Vinod Kumar Singh's contributions to pharmaceutical chemistry through his innovative patents are paving the way for advancements in cancer treatment. His dedication to research and collaboration continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile